Comparison of positive rates between glutamic acid decarboxylase antibodies and ElisaRSR™ 3 Screen ICA™ in recently obtained sera from patients who had been previously diagnosed with slowly progressive type 1 diabetes

AIMS/INTRODUCTION: This study aimed to compare the positivity rates of glutamic acid decarboxylase autoantibodies (GADA) and ElisaRSR™ 3 Screen ICA™ (3 Screen ICA), a newly developed assay for the simultaneous measurement of GADA, insulinoma‐associated antigen‐2 autoantibodies (IA‐2A), and zinc tran...

Descripción completa

Detalles Bibliográficos
Autores principales: Takehana, Nobuaki, Fukui, Tomoyasu, Mori, Yusaku, Hiromura, Munenori, Terasaki, Michishige, Ohara, Makoto, Takada, Michiya, Tomoyasu, Masako, Ito, Yoshihisa, Kobayashi, Tetsuro, Yamagishi, Sho‐ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286791/
https://www.ncbi.nlm.nih.gov/pubmed/37082800
http://dx.doi.org/10.1111/jdi.14016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10286791/
https://www.ncbi.nlm.nih.gov/pubmed/37082800
http://dx.doi.org/10.1111/jdi.14016

Ejemplares similares